Top compounds associated with response to CLDN16


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.089 0.01
mRNA Y-39983 GDSC1000 pan-cancer AAC -0.084 0.01
mRNA Vorinostat gCSI pan-cancer AAC -0.16 0.01
mRNA TGX221 GDSC1000 pan-cancer AAC -0.12 0.01
mRNA bid1870 gCSI pan-cancer AAC 0.16 0.02
mRNA CMK GDSC1000 pan-cancer AAC 0.13 0.02
mRNA Vandetanib FIMM pan-cancer AAC 0.49 0.02
mRNA pac-1 GDSC1000 pan-cancer AAC 0.089 0.02
mRNA lapatinib FIMM pan-cancer AAC 0.44 0.03
mRNA Epothilone B FIMM pan-cancer AAC 0.45 0.03
Download CSV